CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $1.52M invested in Can-Fite BioPharma in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

6% less capital invested

Capital invested by funds: $1.62M → $1.52M (-$103K)

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$264K
2
+$59.4K
3
+$5.03K
4
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
+$3.11K

Top Sellers

1
-$34.5K
2
-$27K
3
-$27K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.31M
2
$102K
3
$59.4K
4
$34.1K
5
$6.03K
6
$5.03K
7
$1.21K
8
$1.11K
9
$402
10
$372
11
$38
12
–
13
–